Keros Therapeutics, Inc. financial data

Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1050 Waltham Street, Suite 302, Lexington, MA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.11K % +13.8%
Debt-to-equity 7.92 % -18.8%
Return On Equity -37.9 % +19%
Return On Assets -35.1 % +17.6%
Operating Margin -5.94K % +94.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.6M shares +12.4%
Common Stock, Shares, Outstanding 40.6M shares +27.4%
Entity Public Float 1.3B USD +43.6%
Common Stock, Value, Issued 4K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 37.4M shares +27.1%
Weighted Average Number of Shares Outstanding, Diluted 37.4M shares +27.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.55M USD +2251%
Research and Development Expense 174M USD +28.4%
General and Administrative Expense 40.8M USD +17%
Operating Income (Loss) -211M USD -24.1%
Nonoperating Income (Expense) 23.8M USD +40.3%
Net Income (Loss) Attributable to Parent -187M USD -22.5%
Earnings Per Share, Basic -5 USD/shares +3.85%
Earnings Per Share, Diluted -5 USD/shares +3.85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 560M USD +69.1%
Accounts Receivable, after Allowance for Credit Loss, Current 2.74M USD +1817%
Other Assets, Current 1.48M USD +48%
Assets, Current 589M USD +69.6%
Property, Plant and Equipment, Net 4.24M USD +2.49%
Operating Lease, Right-of-Use Asset 19.3M USD +25.5%
Other Assets, Noncurrent 2.06M USD +0.2%
Assets 616M USD +66.4%
Accounts Payable, Current 4.6M USD -15.6%
Employee-related Liabilities, Current 10.1M USD +34.3%
Accrued Liabilities, Current 20.9M USD +16.5%
Liabilities, Current 27.5M USD +12.6%
Operating Lease, Liability, Noncurrent 16.9M USD +25.6%
Liabilities 44.3M USD +17.2%
Retained Earnings (Accumulated Deficit) -569M USD -49.1%
Stockholders' Equity Attributable to Parent 572M USD +72%
Liabilities and Equity 616M USD +66.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -44.6M USD -30.2%
Net Cash Provided by (Used in) Financing Activities 157M USD +45.6%
Net Cash Provided by (Used in) Investing Activities -946K USD +10.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 40.6M shares +27.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 111M USD +53.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 561M USD +68.9%
Deferred Tax Assets, Valuation Allowance 150M USD +51%
Deferred Tax Assets, Gross 155M USD +50.6%
Operating Lease, Liability 18.9M USD +30.6%
Depreciation 277K USD +65.9%
Payments to Acquire Property, Plant, and Equipment 946K USD -10.9%
Lessee, Operating Lease, Liability, to be Paid 25.8M USD +20.8%
Property, Plant and Equipment, Gross 7.19M USD +22.8%
Operating Lease, Liability, Current 1.98M USD +96.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4M USD +59.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.8M USD +56.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.94M USD +0.29%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.13M USD +60%
Deferred Tax Assets, Operating Loss Carryforwards 45.1M USD +24.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.25M USD +60%
Operating Lease, Payments 500K USD +150%
Additional Paid in Capital 1.14B USD +59.8%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 5.17M USD +41%
Share-based Payment Arrangement, Expense 34.9M USD +21.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%